Patterson Sandra 4
4 · GILEAD SCIENCES, INC. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Patterson Sandra
SVP, Controllership
Transactions
- Exercise/Conversion
Common Stock
2024-09-10+901→ 36,877 total - Exercise/Conversion
Restricted Stock Unit
2024-09-10−901→ 13,183 total→ Common Stock (901 underlying) - Tax Payment
Common Stock
2024-09-10$81.44/sh−292$23,780→ 36,585 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.